Image	Title	Link
	Q&A Session	More ...
	Impact of cirrhosis and HE on patient‘s quality of life	More ...
	The Gut-liver-muscle Axis	More ...
	Role of Microbiome in Cirrhosis and HE	More ...
	New insights from NAFLD and NASH	More ...
	New therapeutic targets of LOLA	More ...
	Hepatic Encephalopathy	More ...
	Outlook – liver awareness and research	More ...
	Challenges in HE	More ...
	Outlook – liver awareness and research	More ...
	Challenges in HE	More ...
	Efficacy of LOLA in hepatic encephalopathy (36 min)	More ...
	Webinar LOLA efficacy PSSLD (32 min)	More ...
	Sarcopenia in Cirrhosis	More ...
	Update Hepatic Encephalopathy in Cirrhosis –potential Role of L-Ornithin-L-Aspartate	More ...
	Hepaticencephalopathy in clinical practice-more than just brain fog–a typical case presentation	More ...
	Discussion 2	More ...
	Future trends and directions of rL-ornithine L-aspartate	More ...
	Ammonia: friend or foe?	More ...
	New therapeutic agents for LOLA	More ...
	Sarcopenia in cirrhosis and hepatic encephalopathy	More ...
	Discussion 1	More ...
	Meta-analysisof LOLA: Impact of future patient management	More ...
	Pathogenesis and mechanisms of actionof L-ornithine L-aspartate	More ...
	Principles of HE management and impact on patient`s quality of life	More ...